# Lung Cancer Screening Eligibility Assessment

> **NCT06133816** · NA · COMPLETED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 6125 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **BEHAVIORAL:** Framed Introductory Message A
- **BEHAVIORAL:** Framed Introductory Message B
- **BEHAVIORAL:** Framed Introductory Message C
- **BEHAVIORAL:** Framed Tobacco Use Message A
- **BEHAVIORAL:** Framed Tobacco Use Message B
- **BEHAVIORAL:** Financial Incentive

## Key facts

- **NCT ID:** NCT06133816
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-31
- **Primary completion:** 2024-01-31
- **Final completion:** 2024-01-31
- **Target enrollment:** 6125 (ACTUAL)
- **Last updated:** 2025-05-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06133816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06133816, "Lung Cancer Screening Eligibility Assessment". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06133816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*